Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721562 · ClinicalTrials.gov registry record
Antibiotic Resistance in Global Pediatric Oncology Centers
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 560
- Enrollment target
NCT03721562: Completed study, sponsored by St. Jude Children's Research Hospital.
NCT03721562 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 560 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03721562 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 560 participants
- Enrollment target
Study Summary
Antibiotic resistance is one of the major health threats facing global as well as domestic populations, however it is not well characterized in pediatric patients. Pediatric patients receiving cancer-directed therapy have several risk factors implicated in development of antibiotic resistance including multiple courses of antibiotics, repeated exposures to the hospital environment, indwelling devices and chemotherapy-related damage to mucosal barriers. The investigators propose to capitalize upon the unique position of St. Jude Global within the global pediatric oncology community by using its regional alliance network to describe the molecular epidemiology of antibiotic resistance in Gram-negative bacteria in this population. Primary Objectives 1. Describe the epidemiology and the phenotypic and previously determined molecular determinants of antimicrobial resistance in Gram-negative organisms isolated from pediatric diagnostic specimens in selected Central American and US sites with capacity to treat pediatric cancer 2. Utilize strain typing by whole genome sequencing to describe relatedness between organisms at participating sites
Primary Outcome
Number of isolated organisms by anatomic site and geographic site
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 560 participants |
| Start Date | 2019-02-26 |
| Est. Completion | 2022-07-29 |
What the finished NCT03721562 record still lists
NCT03721562 is an observational study that tracks outcomes without assigning an intervention. The registered 560 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03721562 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03721562 about?
NCT03721562 is a clinical study titled "Antibiotic Resistance in Global Pediatric Oncology Centers". Antibiotic resistance is one of the major health threats facing global as well as domestic populations, however it is not well characterized in pediatric patients. Pediatric patients receiving cancer-directed therapy have several risk factors implicated in development of antibiotic resistance includ...
What is the current status of trial NCT03721562?
This trial is currently completed. The enrollment target is 560 participants. The study started on 2019-02-26. Estimated completion is 2022-07-29.
Who is sponsoring clinical trial NCT03721562?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04661358 · 560 participants · Phase 3
Fenofibrate for Prevention of DR Worsening
- NCT05473871 · 560 participants · NA
Enhancing Capacity in Churches to Implement PA Programs
- NCT06001541 · 560 participants · NA
Web-based Program to Improve Self-management Among Veterans-caregiver Dyads
- NCT06246916 · 560 participants · Phase 3
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI